Literature DB >> 1065390

Further characterization of the circulating cell in chronic lymphocytic leukemia.

E F Schultz, S Davis, A D Rubin.   

Abstract

Peripheral lymphocytes from normal individuals and from patients with chronic lymphocytic leukemia (CLL) were cultured in vitro for 1-7 days. The growth response to phytohemagglutinin (PHA) was quantitated by the incorporation of tritiated uridine into RNA nucleotide during a 2-hr pulse with the radioisotope. While the maximum response in PHA-stimulated normal cultures appeared at 2-3 days, CLL cultures required 5-7 days to develop their maximal response, which was 50%-60% of the normal magnitude. Dilution of the number of normally reactive lymphocytes by culturing them with totally unreactive, mitomycin-treated cells produced a normal 72-hr maximal response, no matter what proportion of unreactive cells was included in the PHA-stimulated cultures. In addition, the response of peripheral lymphocytes from patients with myeloblastic leukemia, where large numbers of unreactive myeloblasts diluted the normal small lymphocytes, a depressed reaction occurred at the anticipated 2-3 days. Nylon fiber-adherent lymphocytes consisting of 85% immunoglobulin (Ig)-bearing cells responded minimally to PHA, but showed no evidence of a delay. When isolated from CLL patients, both fiber-adherent cells (Ig-bearing) as well as non-fiber-adherent (sheep erythrocyterosetting) cells responded to PHA in a delayed fashion. Similarly, a case of CLL, in which 93.5% of the circulating lymphocytes bore sheep red blood cell receptors, showed its peak response to PHA at 7 days. Therefore, using surface marker criteria considered characteristic of normal T cells and B cells, the delayed response to PHA on the part of CLL lymphocytes was independent of thymic or nonthymic origin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1065390

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.

Authors:  G B Faguet
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

2.  PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.

Authors:  K H Robert
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

3.  B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.

Authors:  K H Robèrt; E Möller; G Gahrton; H Eriksson; B Nilsson
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

4.  Abnormal T-cell functions in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: report of a case with demonstrated "polyclonality" of T lymphocytes.

Authors:  G Lucivero; J T Prchal; A R Lawton; S Antonaci; L Bonomo
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

5.  Chronic lymphocytic leukemia: temporal changes in numbers of T-lymphocytes.

Authors:  L A Fernandez; J M MacSween; G R Langley
Journal:  Can Med Assoc J       Date:  1980-04-19       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.